Key result
In a case series of 8 patients with atheroembolic renal disease, diagnosis was confirmed by kidney biopsy showing cholesterol clefts, highlighting the variability in clinical presentation and the necessity of biopsy for definitive diagnosis.
Why the study?
Atheroembolic renal disease is an underdiagnosed condition with variable clinical presentation.
Case Report (n=8)
No
Atheroembolic renal disease can present with progressive renal failure even in the absence of recent vascular interventions, highlighting the importance of kidney biopsy for definitive diagnosis in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Biopsy aids definitive diagnosis in atypical progressive renal failure; leaves open questions on incidence and management in larger cohorts.
Atheroembolic renal disease (AERD), a part of systemic cholesterol embolization syndrome, is caused by the occlusion of small arteries in the kidneys by cholesterol crystal emboli from ulcerated atherosclerotic plaques. Kidney is commonly involved because of its proximity to the abdominal aorta and its enormous blood supply. AERD is an under diagnosed condition. We report eight cases of AERD, highlighting the variability in its clinical presentation and the importance of a renal biopsy to arrive at a definitive diagnosis.
No takes yet. Share an insight, caveat, or question.
A 2019 study conducted a case report in Atheroembolic renal disease (n=8). Atheroembolic renal disease was evaluated on Clinical characteristics, biopsy findings, and outcomes. In a case series of 8 patients with atheroembolic renal disease, diagnosis was confirmed by kidney biopsy showing cholesterol clefts, highlighting the variability in clinical presentation and the necessity of biopsy for definitive diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: